Your browser doesn't support javascript.
loading
"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma.
Al-Ahmad, Mona; Arifhodzic, Nermina; Nurkic, Jasmina; Maher, Ahmed; Rodriguez-Bouza, Tito; Al-Ahmed, Nasser; Sadek, Ali; Jusufovic, Edin.
Affiliation
  • Al-Ahmad M; Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait, Kuwait.
  • Arifhodzic N; Al-Rashed Allergy Center, Ministry of Health, Kuwait, Kuwait.
  • Nurkic J; Al-Rashed Allergy Center, Ministry of Health, Kuwait, Kuwait.
  • Maher A; Al-Rashed Allergy Center, Ministry of Health, Kuwait, Kuwait.
  • Rodriguez-Bouza T; Al-Rashed Allergy Center, Ministry of Health, Kuwait, Kuwait.
  • Al-Ahmed N; Al-Rashed Allergy Center, Ministry of Health, Kuwait, Kuwait.
  • Sadek A; Al-Rashed Allergy Center, Ministry of Health, Kuwait, Kuwait.
  • Jusufovic E; National Center of Health Information, Ministry of Health, Kuwait, Kuwait.
Med Princ Pract ; 27(3): 260-266, 2018.
Article in En | MEDLINE | ID: mdl-29414831

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents / Omalizumab Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Med Princ Pract Journal subject: EDUCACAO Year: 2018 Document type: Article Affiliation country: Kuwait Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents / Omalizumab Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Med Princ Pract Journal subject: EDUCACAO Year: 2018 Document type: Article Affiliation country: Kuwait Country of publication: Switzerland